8,200 Shares in Revvity, Inc. (NYSE:RVTY) Bought by Levin Capital Strategies L.P.

Levin Capital Strategies L.P. bought a new position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,200 shares of the company's stock, valued at approximately $896,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of RVTY. Vanguard Group Inc. purchased a new stake in Revvity during the 3rd quarter worth about $1,579,487,000. Ceredex Value Advisors LLC purchased a new stake in shares of Revvity in the 4th quarter valued at about $108,353,000. Swiss National Bank purchased a new stake in shares of Revvity in the 4th quarter valued at about $42,434,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in shares of Revvity in the 4th quarter valued at about $33,568,000. Finally, Boston Trust Walden Corp purchased a new stake in shares of Revvity in the 4th quarter valued at about $25,154,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Revvity

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the stock in a transaction on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the transaction, the insider now owns 92,801 shares of the company's stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on RVTY. KeyCorp boosted their target price on Revvity from $110.00 to $126.00 and gave the stock an "overweight" rating in a research report on Friday, February 2nd. UBS Group cut Revvity from a "buy" rating to a "neutral" rating and boosted their target price for the stock from $105.00 to $125.00 in a research report on Tuesday, January 16th. Raymond James boosted their target price on Revvity from $106.00 to $127.00 and gave the stock an "outperform" rating in a research report on Friday, February 2nd. Robert W. Baird boosted their target price on Revvity from $126.00 to $127.00 and gave the stock an "outperform" rating in a research report on Tuesday. Finally, Barclays boosted their target price on Revvity from $92.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $118.17.

Revvity Price Performance

RVTY stock traded down $1.53 on Thursday, reaching $101.07. The company had a trading volume of 675,087 shares, compared to its average volume of 848,062. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $132.54. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.23. The company's fifty day moving average is $104.63 and its 200 day moving average is $101.32. The company has a market cap of $12.49 billion, a P/E ratio of 83.53, a PEG ratio of 2.67 and a beta of 1.09.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.04. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The firm had revenue of $649.90 million for the quarter, compared to analyst estimates of $646.83 million. During the same quarter in the prior year, the company earned $1.01 EPS. Revvity's revenue was down 3.7% on a year-over-year basis. On average, research analysts forecast that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Friday, July 19th. Revvity's payout ratio is currently 23.14%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.